INSIGHTS ON PHARMACEUTICAL PACKAGING

• Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To Commercialization

  While in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharmaceuticals company sought a packaging recommendation: a stopper to maintain high-quality standards.

• Characterizing The E&L Profile Of Stoppers For Drug Stability

  The significance of E&L testing lies in its ability to identify potential risks associated with the use of containers and packaging materials in the pharmaceutical industry.

• The Importance Of Containment In Oral Solid Dose Packaging Systems

  Containment is growing in importance due to increasingly stringent legal requirements for packaging solid medicines. Learn in detail about containment solutions for the pharmaceutical industry.

• Lifecycle Planning For Containment And Delivery Of Biologics Drug Products

  Read more about trends in the biologics market that could impact the lifecycle strategies for your drug product and steps you can take around drug packaging early in development.

• Single Unit Dose Nasal Spray Carton Provides Cost Savings

  8/1/2024

  Gain insight into how switching to a single-unit dose nasal sprayer carton reduced one company's material costs and significantly improved environmental sustainability throughout the product lifecycle.

• Stick-Pack Benefits For Pharmaceuticals And Nutraceuticals

  10/24/2024

  Explore the key advantages of stick-pack formats for pharmaceuticals and nutraceuticals, from enhanced product safety and cost-efficiency to improved compliance and marketability.

• The Enhanced Version Of Ready-To-Use Vial Platform

  1/13/2025

  Discover a platform for aseptic manufacturing that offers pre-sterilized vials for biologics to improve efficiency and safety with automated filling systems and advanced packaging for optimized drug containment.

• Providing Packing And Blinding Solutions For An Innovative Drug Start-Up

  9/13/2024

  Discover how a CDMO with integrated services enabled a botanical drug start-up to commence its Phase 1 clinical trial, paving the way for further advancement of its innovative botanical drug.

• Improve Speed To Market By Mitigating Vial And Stopper Incompatibility

  10/1/2024

  These studies indicate that with a properly assembled vial containment system, good CCI performance can be achieved with stoppers of a given elastomer, independent of configuration/size, or vial style.